Zealand Pharma launches long-term incentive programs for board of directors

Zealand Pharma (ZLDPF) announces the implementation of long-term incentive programs for 2025 for Zealand Pharma’s Board of Directors, Corporate Management and employees in accordance with Zealand Pharma’s remuneration policy and overall guidelines for incentive pay, as adopted at the annual general meeting held on March 20, 2024. Zealand Pharma has made the following awards in its long-term incentive plan. It has awarded: 29,169 restricted share units to Zealand Pharma’s Board of Directors; 96,788 performance share units and 96,788 RSUs have been awarded to Zealand Pharma’s Corporate Management; 18,502 RSUs have been awarded to Zealand Pharma’s US employees and 128,519 RSU’s have been awarded to Zealand Pharma’s employees in Denmark.